Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

NCT00791544 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped Company decision to discontinue the AVE1642 development program, not due to any safety or efficacy concerns

Conditions

Interventions

Sponsor

Sanofi